A citation-based method for searching scientific literature

P Bönöczk, B Gulyás, V Adam-Vizi, A Nemes, E Kárpáti, B Kiss, M Kapás, C Szántay, I Koncz, T Zelles, A Vas. Brain Res Bull 2000
Times Cited: 97







List of co-cited articles
534 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism.
Kye-Im Jeon, Xiangbin Xu, Toru Aizawa, Jae Hyang Lim, Hirofumi Jono, Dong-Seok Kwon, Jun-Ichi Abe, Bradford C Berk, Jian-Dong Li, Chen Yan. Proc Natl Acad Sci U S A 2010
155
29

Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.
S Szakáll, I Boros, L Balkay, M Emri, I Fekete, L Kerényi, S Lehel, T Márián, T Molnár, J Varga,[...]. J Neuroimaging 1998
42
52

Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey.
B Gulyás, C Halldin, P Karlsson, Y H Chou, C G Swahn, P Bönöck, M Paróczai, L Farde. J Neuroimaging 1999
34
55



Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Géza Szilágyi, Zoltán Nagy, László Balkay, István Boros, Miklós Emri, Szabolcs Lehel, Teréz Márián, Tamás Molnár, Szabolcs Szakáll, Lajos Trón,[...]. J Neurol Sci 2005
36
44




Eburnamine derivatives and the brain.
Adám Vas, Balázs Gulyás. Med Res Rev 2005
61
22

Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
Xiaoping Zhou, Xiao-Wei Dong, James Crona, Maureen Maguire, Tony Priestley. J Pharmacol Exp Ther 2003
52
25

Ethyl apovincaminate therapy in neurovascular diseases.
A Szobor, M Klein. Arzneimittelforschung 1976
36
36


Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration.
Yujun Cai, Walter E Knight, Shujie Guo, Jian-Dong Li, Peter A Knight, Chen Yan. J Pharmacol Exp Ther 2012
43
30




Synaptosomal response to oxidative stress: effect of vinpocetine.
M S Santos, A I Duarte, P I Moreira, C R Oliveira. Free Radic Res 2000
41
29


PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
B Gulyás, C Halldin, J Sandell, P Karlsson, J Sóvágó, E Kárpáti, B Kiss, A Vas, Z Cselényi, L Farde. Acta Neurol Scand 2002
45
26


Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
Balázs Gulyás, Christer Halldin, Judit Sóvágó, Johan Sandell, Zsolt Cselényi, Adám Vas, Béla Kiss, Egon Kárpáti, Lars Farde. Eur J Nucl Med Mol Imaging 2002
34
32


Vinpocetine prevents ischemic cell damage in rat hippocampus.
D Sauer, R Rischke, T Beck, C Rossberg, H D Mennel, G W Bielenberg, J Krieglstein. Life Sci 1988
67
14


Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Adám Vas, Balázs Gulyás, Zsolt Szabó, Péter Bönöczk, László Csiba, Béla Kiss, Egon Kárpáti, Gyula Pánczél, Zoltán Nagy. J Neurol Sci 2002
21
47


The synthesis of ethyl apovincaminate.
C Lörincz, K Szász, L Kisfaludy. Arzneimittelforschung 1976
29
34

[11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies.
Balázs Gulyás, Christer Halldin, Adám Vas, Richard B Banati, Evgeny Shchukin, Sjoerd Finnema, Jari Tarkainen, Károly Tihanyi, Géza Szilágyi, Lars Farde. J Neurol Sci 2005
41
24

Role of vinpocetine in cerebrovascular diseases.
Sazal Patyar, Ajay Prakash, Manish Modi, Bikash Medhi. Pharmacol Rep 2011
53
18



Vinpocetine for cognitive impairment and dementia.
S Z Szatmari, P J Whitehouse. Cochrane Database Syst Rev 2003
57
15


Vincamine and vincanol are potent blockers of voltage-gated Na+ channels.
S A Erdo, P Molnár, V Lakics, J Z Bence, Z Tömösközi. Eur J Pharmacol 1996
26
30




Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
V L Feigin, B M Doronin, T F Popova, E V Gribatcheva, D V Tchervov. Eur J Neurol 2001
40
20

A systematic review of vinpocetine therapy in acute ischaemic stroke.
D Bereczki, I Fekete. Eur J Clin Pharmacol 1999
24
33


Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
M Miyamoto, T H Murphy, R L Schnaar, J T Coyle. J Pharmacol Exp Ther 1989
224
8

Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.
David J Nagel, Toru Aizawa, Kye-Im Jeon, Weimin Liu, Amy Mohan, Heng Wei, Joseph M Miano, Vincent A Florio, Pingjin Gao, Vyacheslav A Korshunov,[...]. Circ Res 2006
91
8

Vinpocetine as a potent antiinflammatory agent.
Alexandre E Medina. Proc Natl Acad Sci U S A 2010
44
18

Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
D Kim, S D Rybalkin, X Pi, Y Wang, C Zhang, T Munzel, J A Beavo, B C Berk, C Yan. Circulation 2001
146
8

Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.
Jianhui Zhuang, Wenhui Peng, Hailing Li, Yuyan Lu, Ke Wang, Fan Fan, Shuang Li, Yawei Xu. PLoS One 2013
31
25

TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation.
Yan-Yin Zhao, Jie-Zhong Yu, Qin-Ying Li, Cun-Gen Ma, Chuan-Zhen Lu, Bao-Guo Xiao. Neuron Glia Biol 2011
43
18



Bioavailability of vinpocetine and interference of the time of application with food intake.
A Lohmann, E Dingler, W Sommer, K Schaffler, W Wober, W Schmidt. Arzneimittelforschung 1992
17
41


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.